Amebiasis (Entamoeba histolytica Infection)
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 22, 2017 Category: General Medicine Source Type: news
TECHLAB(R) Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK(TM) To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite
E. HISTOLYTICA QUIK CHEK and GIARDIA/CRYPTOSPORIDIUM QUIK CHEK Provide a definitive diagnosis in parasite screening
BLACKSBURG, Va., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- TECHLAB,® Inc., a leading developer and manufacturer o... Diagnostics, FDA TECHLAB, E. HISTOLYTICA QUIK CHEK, Amebiasis, E. Histolytica (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news
Teaching an old drug new tricks to fight cytomegalovirus
An old drug once mostly used to treat amebiasis -- a disease caused by a parasite -- and induce vomiting in cases of poisoning appears to also halt replication of cytomegalovirus (CMV), a herpesvirus that can cause serious disease in immunocompromised individuals, including those with HIV or organ transplant recipients, report researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 27, 2016 Category: Science Source Type: news
Teaching an old drug new tricks to fight cytomegalovirus
(Johns Hopkins Medicine) Researchers at Johns Hopkins have found that an old drug once mostly used to treat amebiasis -- a disease caused by a parasite -- and induce vomiting in cases of poisoning appears to also halt replication of cytomegalovirus (CMV), a herpesvirus that can cause serious disease in immunocompromised individuals, including those with HIV or organ transplant recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 27, 2016 Category: Global & Universal Source Type: news
Having and Fighting Ebola: Public Health Lessons From a Clinician Turned Patient
While treating patients with Ebola in Guinea, I kept a journal to record my perceived level of risk of being infected with the deadly virus. A friend who'd volunteered previously had told me that such a journal comforted him when he looked back and saw no serious breach of protocol or significant exposure. On a spreadsheet delineating three levels of risk -- minimal, moderate, and high -- I'd been able to check off minimal risk every day after caring for patients. Yet on October 23, 2014, I entered Bellevue Hospital as New York City's first Ebola patient.
Though I didn't know it then -- I had no television and was too wea...
Source: Science - The Huffington Post - March 2, 2015 Category: Science Source Type: news
